CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy - Related Studies

CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy

This study is ongoing, but not recruiting participants.

Study NCT00031941. Last updated on October 18, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Lymphoma
		Small Intestine Cancer

2	Additional conditions recognized in this trial
		Duodenal Neoplasms
		Ileal Neoplasms
		Intestinal Neoplasms
		Jejunal Neoplasms

3	More general conditions related to this trial
		Digestive System Diseases
		Digestive System Neoplasms
		Duodenal Diseases
		Gastrointestinal Diseases
		Gastrointestinal Neoplasms
		Ileal Diseases
		Immune System Diseases
		Immunoproliferative Disorders
		Intestinal Diseases
		Jejunal Diseases
		Lymphatic Diseases
		Lymphoproliferative Disorders
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site

4	Interventions listed in this trial
		lenalidomide

5	More general drug interventions related to this trial
		Antineoplastic Agents
		Pharmacologic Actions
		Therapeutic Uses

6	Sponsors listed in this trial
		NCI - Center for Cancer Research-Medical Oncology
		National Cancer Institute (NCI)